A

Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS

Watchlist Manager
Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS
Watchlist
Price: 450.4 INR 0.04% Market Closed
Market Cap: ₹69B

Net Margin

8.3%
Current
No historical data
Comparison unavailable

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
8.3%
=
Net Income
₹3.4B
/
Revenue
₹41.2B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
8.3%
=
Net Income
₹3.4B
/
Revenue
₹41.2B

Peer Comparison

Country Company Market Cap Net
Margin
IN
Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS
69B INR
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.1T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
212.1B USD
Loading...
US
Danaher Corp
NYSE:DHR
154.9B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
79.2T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
35.6B CHF
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
37.6B USD
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
34.5B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.4B USD
Loading...
US
Waters Corp
NYSE:WAT
22.9B USD
Loading...

Market Distribution

In line with most companies in India
Percentile
61th
Based on 5 531 companies
61th percentile
8.3%
Low
-305 007.7% — 2.1%
Typical Range
2.1% — 11.6%
High
11.6% — 1 221 633.3%
Distribution Statistics
India
Min -305 007.7%
30th Percentile 2.1%
Median 5.8%
70th Percentile 11.6%
Max 1 221 633.3%

Akums Drugs and Pharmaceuticals Ltd
Glance View

Akums Drugs and Pharmaceuticals Ltd., an unsung hero within India's healthcare sector, crafts its narrative through a robust commitment to pharmaceutical manufacturing. Founded in 2004, this company quietly emerged as a formidable provider of contract drug manufacturing solutions. Instead of marketing its own branded products, Akums positions itself as the silent partner behind many well-known pharmaceutical names, providing vital production services. By offering end-to-end manufacturing, from raw material sourcing to finished product packaging, Akums ensures that pharmaceutical companies can concentrate on their strengths: marketing and distribution. The company thrives on its vast portfolio, which encompasses the manufacture of nearly every form of a pharmaceutical product—be it tablets, capsules, injectables, or topical treatments. Akums drives revenue through partnerships, where it functions as the backbone of production lines for its clients. Utilizing cutting-edge technology and stringent global standards, Akums not only addresses the varied needs of the pharmaceutical industry but also adapts to the ever-evolving demands of healthcare worldwide. This strategic focus on high-quality contract manufacturing fuels its financial success, allowing it to expand facilities and scale operations, while maintaining a discreet presence that underscores its core philosophy: to innovate in service rather than spotlight.

AKUMS Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
8.3%
=
Net Income
₹3.4B
/
Revenue
₹41.2B
What is Akums Drugs and Pharmaceuticals Ltd's current Net Margin?

The current Net Margin for Akums Drugs and Pharmaceuticals Ltd is 8.3%, which is in line with its 3-year median of 8.3%.

How has Net Margin changed over time?

Over the last 0 months, Akums Drugs and Pharmaceuticals Ltd’s Net Margin has decreased from 8.3% to 8.3%. During this period, it reached a low of 8.3% on Jun 30, 2025 and a high of 8.3% on Jun 30, 2025.

Back to Top